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AIM OF THE STUDY: To analyze the prevalence of risk factors of  NAFLD and occult 
hepatitis B infection in patients with Non-B Non-C hepatocellular carcinoma 
MATERIALS AND METHODS: Patients with hepato-cellular carcinoma, negative for HBsAg 
and anti–HCV antibody were included in this study done between June 2013 to November 2014,. 
Besides clinical examination, anthropometric measures and routine laboratory investigations, all 
patients underwent testing for antibody against Hepatitis B core antigen (anti-HBc) and 
quantitative PCR for Hepatitis B virus DNA. Occult hepatitis B infection was defined as 
presence of HBV DNA in the absence of HBsAg positivity. All patients were assessed for risk 
factors of NAFLD such as diabetes, hypertension, dyslipidemia, metabolic syndrome, waist hip 
ratio and family history of diabetes mellitus. 
RESULTS: 47 patients with HCC (M:37; Age:60±10 years; mean,SD) were included.  At 
presentation, 11(26%) patients were within Milan criteria and MELD was 11± 4. 25 patients 
were in Child’s class A. Significant alcohol intake (> 20 gm/d for > 5 years) was noted in 
10(23%) patients.  
13(28%) patients were positive for anti-HBc. However, none of the study patients had detectable 
HBV DNA in blood. Prevalence of risk factors for NAFLD were – DM: 22(51%), hypertension: 
16(34%), dyslipidemia: 13(28%) and metabolic syndrome: 21(45%). 34(72.34%) had at least one 
risk factor for NAFLD.   
CONCLUSIONS: 72% of the patients had a risk factor of non alcoholic fatty liver disease. 
None of the patients were positive for occult Hepatitis B infection. Hence NAFLD seems to be 
the major etiological contributing factor in patients with Non B Non C Hepatocellular carcinoma 
in this study. 
 
